Related Articles
Mutations in KRAS codon 12 predict poor survival in Chinese patients with metastatic colorectal cancer
KRAS mutations and subtyping in colorectal cancer in Jordanian patients
Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer
Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first‑line chemotherapy based on fluoropyrimidines and oxaliplatin, with or without bevavizumab: A retrospective analysis
KRAS mutations in patients with colorectal cancer in Libya